SNSE (Sensei Biotherapeutics, Inc. Common Stock) Stock Analysis - AI Report
Sensei Biotherapeutics, Inc. Common Stock (SNSE) is a publicly traded Healthcare sector company. As of May 21, 2026, SNSE trades at $17.58 with a market cap of $26.70M and a P/E ratio of -1.04. SNSE moved +4.59% today. Year to date, SNSE is +80.68%; over the trailing twelve months it is +167.91%. Its 52-week range spans $5.00 to $36.76. Rallies surfaces SNSE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on SNSE?
Rallies AI research for SNSE combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
MILLENNIUM MANAGEMENT LLC bought 1.11K (~$36.99K) on Apr 7, 2026.
MILLENNIUM MANAGEMENT LLC sold 2.12K (~$61.21K) on Apr 7, 2026.
MILLENNIUM MANAGEMENT LLC sold 205 (~$6.09K) on Apr 7, 2026.
SNSE Analyst Consensus
SNSE analyst coverage data. Average price target: $0.00.
Common questions about SNSE
What is the AI research view on SNSE?
Rallies AI research for SNSE combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for SNSE?
Rallies AI research for SNSE combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is SNSE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SNSE. It does not provide personalized investment advice.